Aggressive vs. conservative phototherapy for infants with extremely low birth weight
- PMID: 18971491
- PMCID: PMC2821221
- DOI: 10.1056/NEJMoa0803024
Aggressive vs. conservative phototherapy for infants with extremely low birth weight
Abstract
Background: It is unclear whether aggressive phototherapy to prevent neurotoxic effects of bilirubin benefits or harms infants with extremely low birth weight (1000 g or less).
Methods: We randomly assigned 1974 infants with extremely low birth weight at 12 to 36 hours of age to undergo either aggressive or conservative phototherapy. The primary outcome was a composite of death or neurodevelopmental impairment determined for 91% of the infants by investigators who were unaware of the treatment assignments.
Results: Aggressive phototherapy, as compared with conservative phototherapy, significantly reduced the mean peak serum bilirubin level (7.0 vs. 9.8 mg per deciliter [120 vs. 168 micromol per liter], P<0.01) but not the rate of the primary outcome (52% vs. 55%; relative risk, 0.94; 95% confidence interval [CI], 0.87 to 1.02; P=0.15). Aggressive phototherapy did reduce rates of neurodevelopmental impairment (26%, vs. 30% for conservative phototherapy; relative risk, 0.86; 95% CI, 0.74 to 0.99). Rates of death in the aggressive-phototherapy and conservative-phototherapy groups were 24% and 23%, respectively (relative risk, 1.05; 95% CI, 0.90 to 1.22). In preplanned subgroup analyses, the rates of death were 13% with aggressive phototherapy and 14% with conservative phototherapy for infants with a birth weight of 751 to 1000 g and 39% and 34%, respectively (relative risk, 1.13; 95% CI, 0.96 to 1.34), for infants with a birth weight of 501 to 750 g.
Conclusions: Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. The rate of neurodevelopmental impairment alone was significantly reduced with aggressive phototherapy. This reduction may be offset by an increase in mortality among infants weighing 501 to 750 g at birth. (ClinicalTrials.gov number, NCT00114543.)
2008 Massachusetts Medical Society
Conflict of interest statement
Dr. Fanaroff reports receiving consulting fees, and Dr. Guillet grant support, from Natus. No other potential conflict of interest relevant to this article was reported.
Figures
References
-
- Bratlid D. How bilirubin gets into the brain. Clin Perinatol. 1990;17:449–65. - PubMed
-
- Cashore WJ. The neurotoxicity of bilirubin. Clin Perinatol. 1990;17:437–47. - PubMed
-
- Lucey JF. Bilirubin and brain damage — a real mess. Pediatrics. 1982;69:381–2.
-
- Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics. 1992;90:707–15. - PubMed
-
- Boggs TR, Jr, Hardy JB, Frazier TM. Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months: a preliminary report from the Collaborative Project. J Pediatr. 1967;71:553–60. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U10 HD27851/HD/NICHD NIH HHS/United States
- M01 RR44/RR/NCRR NIH HHS/United States
- U10 HD40492/HD/NICHD NIH HHS/United States
- M01 RR70/RR/NCRR NIH HHS/United States
- U10 HD40521/HD/NICHD NIH HHS/United States
- M01 RR633/RR/NCRR NIH HHS/United States
- M01 RR7122/RR/NCRR NIH HHS/United States
- KL2 RR24149/RR/NCRR NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- U10 HD21385/HD/NICHD NIH HHS/United States
- M01 RR32/RR/NCRR NIH HHS/United States
- UL1 RR24128/RR/NCRR NIH HHS/United States
- U10 HD40689/HD/NICHD NIH HHS/United States
- U10 HD021373/HD/NICHD NIH HHS/United States
- M01 RR6022/RR/NCRR NIH HHS/United States
- U10 HD21364/HD/NICHD NIH HHS/United States
- U10 HD34216/HD/NICHD NIH HHS/United States
- U10 HD27880/HD/NICHD NIH HHS/United States
- U10 HD27904/HD/NICHD NIH HHS/United States
- U10 HD040461/HD/NICHD NIH HHS/United States
- U10 HD40498/HD/NICHD NIH HHS/United States
- U10 HD27871/HD/NICHD NIH HHS/United States
- UL1 RR24148/RR/NCRR NIH HHS/United States
- U10 HD27856/HD/NICHD NIH HHS/United States
- U10 HD40461/HD/NICHD NIH HHS/United States
- U10 HD27853/HD/NICHD NIH HHS/United States
- M01 RR39/RR/NCRR NIH HHS/United States
- M01 RR30/RR/NCRR NIH HHS/United States
- M01 RR80/RR/NCRR NIH HHS/United States
- M01 RR16587/RR/NCRR NIH HHS/United States
- U10 HD21397/HD/NICHD NIH HHS/United States
- U01 HD36790/HD/NICHD NIH HHS/United States
- M01 RR750/RR/NCRR NIH HHS/United States
- M01 RR8084/RR/NCRR NIH HHS/United States
- U10 HD21373/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical